Compare SHIM & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SHIM | OKYO |
|---|---|---|
| Founded | 1990 | 2007 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 97.5M | 79.7M |
| IPO Year | 2023 | 2022 |
| Metric | SHIM | OKYO |
|---|---|---|
| Price | $4.23 | $1.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 69.9K | ★ 322.9K |
| Earning Date | 03-12-2026 | 07-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $495,984,000.00 | N/A |
| Revenue This Year | $6.91 | N/A |
| Revenue Next Year | $13.03 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $1.01 |
| 52 Week High | $4.47 | $3.35 |
| Indicator | SHIM | OKYO |
|---|---|---|
| Relative Strength Index (RSI) | 64.29 | 45.69 |
| Support Level | $3.75 | $1.82 |
| Resistance Level | $4.47 | $2.17 |
| Average True Range (ATR) | 0.35 | 0.22 |
| MACD | 0.03 | -0.04 |
| Stochastic Oscillator | 81.98 | 29.85 |
Shimmick Corp is a provider of water and other critical infrastructure solutions nationwide. It selectively focuses on the following types of infrastructure projects: Water Treatment, Water Resources, and Other Critical Infrastructure. In water treatment projects the company expands, rehabilitates, upgrades, builds and rebuilds water and wastewater treatment infrastructure, including desalination plants. In water resources projects company builds, expands, and improves water storage and conveyance, dams, levees, flood control systems, pump stations, and coastal protection. In Other Critical Infrastructure projects, It builds, retrofits, expands, rehabilitates, operates, and maintains its nation's critical infrastructure, including mass transit, bridges, and military infrastructure.
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.